Lesinurad Tablet Bioequivalence

Status:
Completed

Trial end date:
2014-07-01

Target enrollment:

Participant gender:

This study will assess the bioequivalence of lesinurad tablets manufactured at two different sites.

Phase 1

Ardea Biosciences, Inc.

Lesinurad